Arcana Institute (INAR) is now part of Certara, a global leader in model-informed drug development and regulatory science.

Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides support for drug development through the product’s full life cycle, from clinical trial planning & design, drug registration, Real World Data, strategic support in HEOR and Market Access, up to reimbursement and beyond.

Certara’s staff includes over 700 experts in more than 20 offices worldwide!

Together, we are creating innovative analytical methods to provide our partners with the highest-quality scientific evidence in safety, clinical efficacy and effectiveness for medical technologies.

find out more

Business Partners

Cooperative Institutions


10 May 2018

VI HTA Symposium in Krakow – Confirmed Speakers and Preliminary Program

Arcana Institute is hosting its annual HTA Symposium in Krakow, bringing together recognized experts from public and private sectors to discuss current events and challenges taking place in Poland in  more...
8 May 2018

Purposeful Disarray or Inefficient Approach to Financing of Medical Devices in Poland

Assessing Non-Medical Technologies in Poland Menedżer Zdrowia (Health Manager), a news platform for the medical sector that also produces a monthly magazine, recently published an article written by Arcana  more...
19 April 2018

International Business Development Specialist

Instytut Arcana Sp. z o.o., a Certara company, is seeking candidates for the position of International Business Development Specialist Location: Krakow, Poland About Company Arcana Institute (INAR), a  more...